LifeSphere® Technology is trusted by these industry leaders:
The game has changed for Pharmacovigilance. As case volumes surge, global operations expand, and regulatory complexity increases, PV teams are under pressure to do more with less—without compromising patient safety. While AI and automation are no longer optional, operationalizing them across the end-to-end Safety ecosystem has historically been complex, slow, and costly.
In this guide, we explore how leading life sciences organizations are taking an AI-forward approach—leveraging GenAI and Agentic AI to drive measurable efficiency, scalability, and quality improvements across the PV lifecycle—and what to prioritize when evaluating PV AI solutions and partners to move from pilots to real-world value in weeks, not years.
Key takeaways include:
"*" indicates required fields
Please view our Privacy Policy for information on how ArisGlobal handles customer data.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved